Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-helper type 1 (Th1) immune response is a specialized arm of the adaptive immune system mediated by Th1 cells, a subset of CD4+ helper T cells. Th1 responses are primarily responsible for cell-mediated immunity, which targets intracellular pathogens such as viruses, certain bacteria (e.g., Mycobacterium tuberculosis), and protozoa. Key cytokines produced are interferon-gamma (IFN-γ), interleukin-2 (IL-2) and tumor necrosis factor-beta (TNF-β). Effector functions include activating macrophages to enhance their microbicidal activity, stimulating cytotoxic T lymphocytes (CD8+ T cells) to kill infected host cells and promoting opsonizing antibody production by B-cells. The differentiation into the Th1 lineage is regulated mainly by transcription factors STAT4 and T-bet. While essential for defense against many pathogens, excessive or misdirected Th1 responses can contribute to tissue damage and autoimmune diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-helper type 1 immune response.